Vol. 15 No. 4 (2014)

Published: 2014-12-23

Editorial

The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014

Mario Eandi

97-98
- HTML
- PDF

Original research

Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients

Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro

101-112
- HTML
- PDF
Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy

Daniela Paola Roggeri, Alessandro Roggeri, Vittorio Pengo

113-127
- HTML
- PDF
Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy

Alberto Migliore, Andrea Belisari, Lucia S. D'Angiolella, Emanuele Bizzi, Umberto Massafra, Prisco Piscitelli, Lorenzo Giovanni Mantovani

139-146
- HTML
- PDF
How do European patients feel about the listening skills of primary care physicians? Results from the EUprimecare Project

Carlos Alberto Sánchez Piedra, Sonia García-Pérez, Francisco Javier Prado-Galbarro, Antonio Sarría-Santamera

147-153
- HTML
- PDF
Pharmacoeconomic aspects related to the 13-valent pneumococcal conjugate vaccine: preliminary analysis of the data from the ASL of Viterbo

Silvia Dari, Flavia Verginelli, Silvia Aquilani

155-159
- HTML
- PDF

Review (Economic Analysis)

Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration

Piergiorgio Neri, Ilir Arapi, Chiara Maria Eandi, Vittorio Pirani, Cesare Mariotti, Alfonso Giovannini

129-138
- HTML
- PDF